3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
117
Colonic Neoplasms
30
Rectal Neoplasms
27
Neoplasms
20
Neoplasm Metastasis
19
Esophageal Neoplasms
10
Pancreatic Neoplasms
9
Cholangiocarcinoma
7
Colorectal Cancer Metastatic
6
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Adenocarcinoma Of Esophagus
3
Adenocarcinoma
3
Stomach Neoplasms
2
Prostatic Neoplasms
2
Biliary Tract Neoplasms
2
Thyroid Neoplasms
1
Recurrence
1
Pancreatic Adenocarcinoma
1
Oesophago-gastric Cancer
1
Neoplasms, Second Primary
1
Kidney Neoplasms
1
KRAS and NRAS Wild-type Colorectal Cancer
1
Histiocytosis
1
Gallbladder Neoplasms
1
Exanthema
1
Esophageal Squamous Cell Carcinoma
1
Elderly Metastatic Colorectal Cancer Patients
1
Dihydropyrimidine Dehydrogenase Deficiency
1
Interventions
trifluridine tipiracil drug combination
1
Trastuzumab
1
Panitumumab
1
Oxaliplatin
1
Nivolumab
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Dihydropyrimidine Dehydrogenase Deficiency
×
Panitumumab
×
Gastrointestinal
×
Clear all
NCT06245356
2025-12-10
TRIFLUOX-DP
UNICANCER
Phase 2
Recruiting
73 enrolled